TABLE 1.
Compound | CC50 (μM) in:a |
Fold change (CC50MRP8/CC50WT)c | |
---|---|---|---|
WT cellsb | MRP8-overexpressing cells | ||
Tenofovir | 33,694 ± 839 | 161,076 ± 5,478 | 4.78 |
Tenofovir + 50 μM MK-571 | 34,938 ± 770 | 138,115 ± 976 | 3.95 |
Tenofovir + 100 μM MK-571 | 33,530 ± 466 | 10,713 ± 132 | 0.32 |
Values represent the means ± standard deviations of five independent experiments. The calculation was fitted to Richard's five-parameter dose-response curve (45) (asymmetric sigmoidal, with robust fit). See Materials and Methods for details.
WT, wild type, LLC-PK1 parental cells.
For all compounds there was a significant (P < 0.0001) decrease in toxicity due to MRP8 overexpression based on two-way ANOVA multiple comparison tests assuming equal variance.